Submucous and intracavitary myomas can often be removed through the cervix using an instrument called a resectoscope. The resectoscope is a special type of hysteroscope with a built in wire loop that uses high-frequency electrical energy to cut or coagulate tissue. It was developed for surgery of the bladder and the male prostate over fifty years ago to allow surgery inside an organ without having to make an incision, and has made hysteroscopic myomectomy possible.
Hysteroscopic resection of myomas (hysteroscopic myomectomy)
Submucousand intracavitary myomas can often be removed through the cervix using an instrument called a resectoscope. The resectoscope is a special type of hysteroscope with a built in wire loop that uses high-frequency electrical energy to cut or coagulate tissue. It was developed for surgery of the bladder and the male prostate over fifty years ago to allow surgery inside an organ without having to make an incision, and has made hysteroscopic myomectomy possible.
How is hysteroscopic resection of myomas done?
Just as with a standard hysteroscope, the resectoscope is inserted through the cervix. Because it goes through the cervix, it is not necessary to make an incision. Procedures using the resectoscope are done in an operating room setting, such as in an outpatient surgery center. This can at times be done under local anesthesia, but most women prefer to be completely asleep with general anesthesia.
The resectoscope is far more efficient at removing tissue (such as fibroids or large polyps) than conventional instruments. Because of this, the resectoscope should be used only by physicians who have training in its use and who use it on a regular basis.
View through the resectoscope of actual removal of fibroid
The medical information presented in this website represents the opinion of Dr. Indman, and is based on his knowledge and experience. It is not applicable to all patients or physicians. Anyone visiting this or other related medical sites should discuss symptoms, findings, and alternatives with their personal gynecologist.
Visit Dr. Paul Indman's site:All About Myomectomy for Removal of Uterine Fibroids
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More